StockData
Spruce Biosciences, Inc. logo

Spruce Biosciences, Inc. (SPRB) stock

SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$40.84+0.35 (+0.86%)

Close on Nov 18, 2026Market cap $117.38MP/E –Yield –

Spruce Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Spruce Biosciences's price to sales ratio was 62.7× on Jan 30, 2026, against 163.6× a year earlier. Over the last 3 years it ranged from 1.6× to 238.4×, with a median of 22.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 202662.7×−7.7
2025Dec 31, 202570.4×+68.0
2024Dec 31, 20242.4×−14.1
2023Dec 29, 202316.6×–

More Spruce Biosciences figures

See a number that looks wrong?